Released August 2nd, 2023
Julia Angeles - Argenx: Changing Lives with Llamas
Julia Angeles is an investment manager at Baillie Gifford. We cover the types of autoimmune diseases argenx develops treatments for, how it navigates the world of clinical trials and regulatory approval, and what investors and operators can learn from its commercial success.
Professional Investors
Public Equity
Listen now on
You must be logged in to view this content. Don't have an account? Register here. (It's free)